	Obesity-driven extracellular vesicle signaling in cancer: mechanistic insights and clinical implications. Oncogenesis Chakrapani LN, Velasquez J, Suresh J, Sridhar SD, Sankaran R, Arivazhagan SP, Shanmugam A, Dorayappan KDP, O'Malley DM, Muthusamy T, Selvendiran K. PMID: 42386697 [PubMed - as supplied by publisher]
	A Scoping Review of Malnutrition Risk Prediction Models in Cancer Patients. J Clin Nurs Tang N, Zeng H, He B, Zheng Y, Li Q, Li F, Xiao T, Zhou L, Tang A, Chen X. PMID: 42386389 [PubMed - as supplied by publisher]
	Usefulness of indigo carmine chromoendoscopy for detecting gastric cancer and gastric adenoma during upper gastrointestinal endoscopy (INDIGO study): protocol for a prospective multicentre observational study. BMJ Open Gastroenterol Yasuda T, Matsubayashi J, Ishikawa H, Takizawa K. PMID: 42386351 [PubMed - indexed for MEDLINE]
	Patient-centred approach to improve colorectal cancer screening (CRC) in resource-limited communities. BMJ Open Qual Arman O, Reynolds JL, Gudleski GD, Bakhai S. PMID: 42386327 [PubMed - indexed for MEDLINE]
	DNA polymerase epsilon catalytic subunit (POLE) in cancer: implications for tumor biology and therapeutic strategies - a comprehensive review. Crit Rev Oncol Hematol Gola M, Krazi, Kie, Starzy, Sakowicz-Burkiewicz M, Jereczek-Fossa BA, Godlewski J. PMID: 42386138 [PubMed - as supplied by publisher]
	Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial. Lancet Oncol Hu H, Shen X, Li Y, Zhou J, Liu P, Zhang J, Hou Y, Wang X, Deng J, Zheng Z, Li J, Lan P, Wu X, Kang L, Huang M, He Z, He X, Yang Z, Huang L, Wang H, Wang H, Luo S, Chen D, Xie X, Zhang Y, Zhai X, Li S, Li W, Hu J, Yang T, Wang C, Deng W, Huang Y, Cao W, Li F, Shi L, Ling L, Deng Y. PMID: 42385761 [PubMed - as supplied by publisher]
	Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer. Gynecol Oncol Shahin MS, Lorusso D, Backes FJ, Barretina-Ginesta MP, O'Malley DM, Forget F, Pothuri B, Hietanen S, McCormick CC, Abadie-Lacourtoisie S, O'Cearbhaill RE, Heitz F, Moore RG, Amit A, Willmott LJ, Pérez MR, Burger RA, Redondo A, Chase DM, Romero I, Moore KN, Vergote I, Cloven N, Haslund CA, Graybill WS, Bergamini A, Berton D, Braicu EI, Lim JT, Golembesky AK, Shtessel L, Monk BJ, González-Martín A. PMID: 42385609 [PubMed - as supplied by publisher]
	Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications. Eur J Cancer Wankhede D, Rodriguez MJU, Teich F, Carlsson SV, Brenner H, Hoffmeister M. PMID: 42385607 [PubMed - as supplied by publisher]
	Can we develop prognostic models for estimating life expectancy following a cancer diagnosis? Evaluating model complexity, data requirements, and optimal modelling frameworks. Cancer Epidemiol Cooper HL, Rutherford MJ, Booth S. PMID: 42385590 [PubMed - as supplied by publisher]
	Mitochondrial genome alterations in cancer: From mutations and epigenetics to targeted therapiesack. Biochem Biophys Res Commun Shetty S, Padmasali NM, Adiga D, Kabekkodu SP. PMID: 42385482 [PubMed - as supplied by publisher]
	Colonoscopy utilization and persistent disparities in early onset colorectal cancer: A multistate, multi-institution nested case-control study. Surgery Diskin BE, Husa RA, Castro SA, Wendt SJ, Vita A, Robinson P, Rountree J, Bolourani S, Ullman N, Merath K, Bilchik AJ. PMID: 42385384 [PubMed - as supplied by publisher]
	Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspective. Cancer Treat Rev Raimbourg J, Abdelghani MB, Boige V, Botsen D, Carnot A, Coutzac C, Delaye M, De Sousa Carvalho N, Dos Santos M, Edeline J, Ghiringhelli F, Lambert A, Le Sourd S, Palmieri LJ, Pernot S, Samalin E, Smolenschi C, Vivier-Chicoteau J, Marion S, de la Fouchardière C. PMID: 42385352 [PubMed - as supplied by publisher]
	Empty Versus Full Bladder Protocols in Radiotherapy Planning for Localised Prostate Cancer: A Dosimetric Study. J Med Imaging Radiat Oncol Nield RL, Ramani S, Christie DRH, Trono IL. PMID: 42385367 [PubMed - as supplied by publisher]
	Cell-Free DNA Analysis With Clinicopathologic Factors for Early Detection and Refining Lymph Node Metastasis Risk in T1 Colorectal Cancer: Results From the COSMOS-CRC Study. JCO Precis Oncol Murano T, Ikematsu H, Matsuhashi N, Tsukada Y, Shiozawa M, Kato T, Oki E, Yamaguchi T, Kagawa Y, Kanazawa A, Ohta T, Ouchi A, Uchigata H, Notake C, Forouzmand E, He Y, Raymond VM, Duenwald S, Bando H, Yoshino T, Nakamura Y. PMID: 42385102 [PubMed - indexed for MEDLINE]
	Cancer Survival for Selected Cancers in TÃ¼rkiye (2008-2017): A Population-Based Study. Int J Cancer Zahwe M, Eser S, Bardot A, Karakilinc H, Akpinar GC, Akin U, Karasahin EF, Kurnali B, Yakut C, Altinisik M, Ucuncu N, Sunguc C, Znaor A, Soerjomataram I. PMID: 42384957 [PubMed - as supplied by publisher]
	Reliability of cancer screening questions from the National Health Interview Survey. PLoS One Kessler LG, Comstock B, Aiello Bowles EJ, Mou J, Nash MG, Bravo P, Fleckenstein LE, Pflugeisen C, Gao H, Winer RL, Ornelas IJ, Smith C, Neslund-Dudas C, Shetty P, Raghavan UG. PMID: 42384630 [PubMed - indexed for MEDLINE]
	First-Line Enfortumab Vedotin Plus Pembrolizumab vs Gemcitabine Plus Cisplatin for Metastatic Urothelial Carcinoma. JAMA Netw Open Velasquez EL, Titus RS, Nguyen DD, Riveros C, Lalani AK, Kaushik D, Sonpavde GP, Grivas P, Wallis CJD, Satkunasivam R. PMID: 42384383 [PubMed - indexed for MEDLINE]
	SNAP Participation and Cancer Screening for Adults With Food Insecurity. JAMA Netw Open Mevawalla A, Chatzipanagiotou OP, Sarfraz A, Alizai Q, Angez M, Elemosho A, Chaudhry MQ, Zindani S, Pawlik TM. PMID: 42384379 [PubMed - indexed for MEDLINE]
	Longitudinal assessment of health-related quality of life in patients with borderline and locally advanced pancreatic cancer undergoing neoadjuvant FOLFIRINOX chemotherapy: results from a prospective multicenter trial. Langenbecks Arch Surg de Carvalho LFA, Ceelen W, Meertens A, Rashidian N, Waked B, Geboes K, Ribeiro S, Gorleer K, Dedecker H, Triest L, Vervaecke A, Sas S, Sierens B, Beyls C, Sie M, van Dijk M, Verhaeghe N, Berrevoet F. PMID: 42384236 [PubMed - as supplied by publisher]
	Risk factors for one-year mortality and the subsequent prognosis in older patients undergoing curative surgery for colorectal cancer: a retrospective multicenter study. Surg Today Hashimoto S, Tominaga T, Noda K, Shiraishi T, Yamashita M, Katayama H, Tei S, Hida T, Maruta H, Takamura Y, Ono R, Hisanaga M, Ishii M, Moriyama M, Fukuoka H, To K, Oishi K, Takeshita H, Sawai T, Nonaka T, Matsumoto K. PMID: 42384212 [PubMed - as supplied by publisher]

Articles 1 - 20 / 241949

Page 1 of 12098



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy